NEWS

Inovio Pharmaceuticals Demonstrates PSA Stabilizing Effect of INO-5150 Immunotherapy in Phase 1b Study for … – GlobeNewswire (press release)

2018-05-17 Michael Zand NEWS

Daily Brief: Immunotherapy combos dominate ASCO, Pharma’s … – PMLiVE

Inovio Pharmaceuticals Demonstrates PSA Stabilizing Effect of INO-5150 Immunotherapy in Phase 1b Study for …
GlobeNewswire (press release)
Previously reported data from a Phase 1b clinical trial demonstrated that Inovio’s cancer immunotherapy (INO-5150) slowed PSA rise in patients with biochemically recurrent prostate cancer. Additional analyses show clinically meaningful PSA …

2018-05-17 Michael Zand NEWS

Daily Brief: Immunotherapy combos dominate ASCO, Pharma’s … – PMLiVE

PMLiVE

Daily Brief: Immunotherapy combos dominate ASCO, Pharma’s …
PMLiVE
Hello and welcome to a rapid round-up of some of today’s most eyecatching stories from pharma, biotech and healthcare. ASCO17. ASCO. Thousands of …

and more »

2018-05-17 Michael Zand NEWS

GP-write has big goals for synthetic genomes – Phys.Org

Phys.OrgGP-write has big goals for synthetic genomesPhys.OrgIn the first session of the day we got talks and a panel discussion among some premiere synthetic biology leaders: George Church, Jef Boeke, Pam Silver, and Farren Isaacs. They introduced and … Continue reading

2018-05-17 Michael Zand NEWS

Obsidian Presents Preclinical Data at ASGCT Showing Advancement of Its Regulated IL12 and IL15 Programs to … – Business Wire (press release)

Business Wire (press release)Obsidian Presents Preclinical Data at ASGCT Showing Advancement of Its Regulated IL12 and IL15 Programs to …Business Wire (press release)“IL12 and IL15 are critical factors that promote CAR-T cell expansion, persistence, … Continue reading

2018-05-17 Michael Zand NEWS

Obsidian Presents Preclinical Data at ASGCT Showing Advancement of Its Regulated IL12 and IL15 Programs to … – Business Wire (press release)

2018-05-17 Michael Zand NEWS

Researchers transplant retinal sheets derived from human embryonic stem cells in retinal degeneration mouse models – News-Medical.net

News-Medical.netResearchers transplant retinal sheets derived from human embryonic stem cells in retinal degeneration mouse modelsNews-Medical.netResearchers affiliated with the Kawasaki INnovation Gateway at SKYFRONT have developed new mouse models of… Continue reading

2018-05-17 Michael Zand NEWS

After nerve-wracking eye surgery, the world comes into focus for early gene therapy recipient – STAT

STATAfter nerve-wracking eye surgery, the world comes into focus for early gene therapy recipientSTATOSTON — The machine looked like a giant eyeball. There was a hole where the pupil should have been, and the technician told Jack Hogan to stick his hea… Continue reading

2018-05-17 Michael Zand NEWS

1
…
89
90
91
92
93
…
3,595

PMLiVE

and more »

Login

Cart

Inovio Pharmaceuticals Demonstrates PSA Stabilizing Effect of INO-5150 Immunotherapy in Phase 1b Study for … – GlobeNewswire (press release)

Daily Brief: Immunotherapy combos dominate ASCO, Pharma’s … – PMLiVE

Daily Brief: Immunotherapy combos dominate ASCO, Pharma’s … – PMLiVE

GP-write has big goals for synthetic genomes – Phys.Org

Obsidian Presents Preclinical Data at ASGCT Showing Advancement of Its Regulated IL12 and IL15 Programs to … – Business Wire (press release)

Obsidian Presents Preclinical Data at ASGCT Showing Advancement of Its Regulated IL12 and IL15 Programs to … – Business Wire (press release)

Researchers transplant retinal sheets derived from human embryonic stem cells in retinal degeneration mouse models – News-Medical.net

After nerve-wracking eye surgery, the world comes into focus for early gene therapy recipient – STAT

Recent Posts

Blog Categories

Blog Categories

Blog Categories

Blog Categories

Blog Categories